GSK Prescription drugs Nigeria has reiterated its dedication to enhance bronchial asthma management amongst kids, as the corporate unveiled Flixotide on the 2019 Annual Paediatric Affiliation of Nigeria Convention (PANCONF) in Ibadan, Oyo State lately.
Flixotide, based on GSK, is a low dose inhaled corticosteroid for prevention of bronchial asthma exacerbation in kids from one yr of age.
Talking on the unveiling, the Medical Director, GSK Nigeria, Dr. Laja Odunuga acknowledged that GSK needs to take care of the well being wants of youngsters with bronchial asthma and be sure that they dwell a wholesome life.
He mentioned: “The idea is to make controller remedy accessible for youngsters who’re lower than 4 years, and the introduction of Flixotide is supposed to fill a spot for the kids that can’t profit from different controller drugs prescribed for the grownup inhabitants.”
On the evaluation of asthmatic situations amongst kids in Nigeria, Odunuga added that, “I believe we’re getting higher. We’re most likely not the place we wish to be however issues are getting higher within the sense that drugs are actually available.
“We’re additionally attempting to deal with the problem of stigmatisation, capability constructing for healthcare professionals equivalent to docs, nurses and pharmacists to make sure that the suitable issues are accomplished on the proper time.
“For the mother and father, we’re advocating that they take up correct health-seeking behaviour. If we put all these parameters collectively, these are pointers that can scale back the mortality and morbidity related to this illness.”
The 2019 version of the annual PANCONF is the 50th within the collection and the sixth Worldwide Scientific Convention with the theme “PAN at 50: Successes, Challenges and Prospects”.
Congratulating the affiliation, Odunuga mentioned that the Paediatric Affiliation of Nigeria stays one of many greatest supporters of points regarding kids in Nigeria, including that the physique has turn out to be a voice that can not be discountenanced.